• עמוד ראשי
  • מאמרים
  • Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3
מסגרת עם רקע לכותרת

Focal and Diffuse Chronic Central Serous Chorioretinopathy Treated With Half-Dose Photodynamic Therapy or Subthreshold Micropulse Laser: PLACE Trial Report No. 3

תמונת נושא מאמר
14.11.2019 | Thomas J. van Rijssena, Elon H.C. van Dijka, Paula Scholzb, Myrte B. Breukinkc, Rocio Blanco-Garavitod, Eric H. Souiedd, Jan E.E. Keunenc, Robert E. MacLarene, Giuseppe Querquesd,f, Sascha Fauserb,g, Susan M. Downese, Carel B. Hoyngc, Camiel J.F. Boon

בשל "הגנת זכויות יוצרים", מובא להלן קישור למאמר בלבד. לקריאתו בטקסט מלא, אנא פנה לספרייה הרפואית הזמינה לך.

 

To compare the outcome between high-density subthreshold micropulse laser (HSML) treatment and half-dose photodynamic therapy (PDT) in chronic central serous chorioretinopathy (cCSC) patients, subdivided based on either focal or diffuse leakage on fluorescein angiography (FA).

 

Retrospective analysis of multicenter randomized controlled trial data.

 

Patients were treated with either half-dose PDT or HSML (both indocyanine green angiography–guided) and categorized in 2 groups, based on focal or diffuse leakage on FA. Clinical outcomes were evaluated at baseline and during follow-up.

 

American Journal of Ophthalmology, Volume 205, p1-10, September 2019
תמונה שהיא חסות של - primyum -חסות קטנה